Zephyrnet Logosu

J&J'nin Tüketici Yan Ürünü Kenvue Alım Satım Fiyatının %22 Üzerinden Kapattı

Tarih:

Johnson ve Johnson’s consumer health spinoff, Kenvue, just solidified its place as the biggest U.S. IPO debut in over a year.

Kenvue’s shares traded at $26.90 each when the market closed on Thursday, a 22% jump from the company’s original asking price of $22, which was in the high end of the range. When it debuted, shares were trading at $25.60.

The company sold 172.8 million shares — an increase from the 151 million it planned on selling. Kenvue raised $3.8 billion from the offering and its valuation jumped from $48 billion at the start of trading to $50 billion when the market closed.

Back in 2021, Johnson & Johnson açıkladı it would split its pharmaceutical brand from its consumer health division, marking one of the biggest changes to its 100-year history. Kenvue, the consumer health arm that owns a slew of household names like Tylenol, Yara bandı ve Neutrogena, announced last week it would brave the icy public markets and go public. 

Daha az arayın. Daha fazlasını kapat.

Özel şirket verilerinde lider tarafından desteklenen hepsi bir arada potansiyel müşteri bulma çözümleriyle gelirinizi artırın.

Johnson & Johnson is still a majority shareholder in Kenvue, representing a 90.9% stake in the company and owning 1.7 billion shares of common stock.

Sign of a bustling public market ahead?

Kenvue’s blockbuster debut may be a sign that the public markets are thawing. There was an unprecedented number of startups that went public in 2021, but the market chilled considerably in 2022. 

Geçen yıl, Getty Images raised $1.9 billion when it debuted back in July, while marketing platform System1 raised $518 million a few months earlier in January. They were part of a mere 91 startups that went public in 2022, per Crunchbase verileri. By comparison, over 400 startups debuted on the stock market in 2021 and 190 debuted in 2020.

In 2022, several companies scrapped or paused their IPO plans as the economic health of the U.S. became more uncertain, but it’s clear many are Doğru zamanı beklemek to go public. Both fast-fashion retailer Shein and fintech platform Şerit are reportedly in talks to explore IPO options no later than 2024.  

Startups, after raising huge rounds at high valuations in 2021, are looking for ways to extend their runways. And the banking crisis that killed Silikon Vadisi Bankası ve rippled out is only causing more uncertainty for risky startups that don’t often meet banks’ loan requirements. 

İlgili Crunchbase Pro sorgusu:

İllüstrasyon: Dom Guzman

Crunchbase Daily ile son finansman turları, satın almalar ve daha fazlasıyla güncel kalın.

A Serisi, şirketin prostat kanseri tedavisiyle başlayan bir radyofarmasötik boru hattı oluşturmasına yardımcı olacak.

Nisan ayında küresel girişim fonlaması, Temmuz 21'den bu yana tek bir ayda kaydedilen ikinci en düşük miktar olan 2022 milyar dolara ulaştı.

spot_img

En Son İstihbarat

spot_img